New study examines the validity of epo testing

Jun 26, 2008

Recombinant human erythropoietin (rHuEpo) is a genetically engineered hormone sometimes misused by high-performance athletes such as cyclists and marathon runners to boost their endurance. The potential misuse of the drug is detected in urine collected from athletes. Since the test was introduced in 2000, 33 labs around the world have been accredited by the World Anti-Doping Agency (WADA) to administer the procedure.

During the last few years, the testing procedure has been criticized by some. Accordingly, a team of researchers investigated the quality of the test results at two WADA labs. They found that the detection power of the test at the two labs was poor.

The Study

The study is entitled, "Testing for Recombinant Human Erythropoietin in Urine: Problems Associated with Current Anti-Doping Testing," and was conducted by Carsten Lundby, Niels J. Achman-Andersen, Jonas J. Thomsen, Anne M. Norgaard and Paul Robach, all of the Copenhagen Muscle Research Center, Copenhagen, Denmark. The findings appear in the online edition of the Journal of Applied Physiology, published by the American Physiological Society.

The researchers conducted the study using eight male volunteers (non-athletes). Following baseline measurements, the volunteers were injected every second day for 14 days with 5,000 IU rHuEpo (the "boosting period"). For the next two weeks, the volunteers received one injection every seven days (the "maintenance" period). Blood samples were drawn before the injections and on eight additional occasions. Urine samples were collected before the blood draws and on six additional days. Exercise tests using a bicycle ergometer were conducted prior to injection and on three other occasions.

Findings and Implications

The rHuEpo administration regimen was effective in increasing the oxygen carrying capacity of all the volunteer subjects, and at the same time, their performance increased. Additionally:


-- Using the samples collected during the boosting phase, Lab A concluded that all the samples were positive for rHuEpo. Lab B determined that none of the samples, despite being identical to Lab A's samples, were positive.

-- For samples collected during the maintenance period, Lab A determined that six of l6 samples were positive and two samples were suspicious. By contrast, Lab B found no positive samples.

-- For samples collected during the post-treatment phase, Lab A concluded that two of 24 samples were positive and three were suspicious. Lab B determined that all 24 samples were negative.

The implication– if applied to athletes – is that there is only a small "risk" of being tested positive for rHuEpo doping while athletic performance is greatly enhanced. If the samples are analyzed by Lab B, the risk of doping detection is non-existent. It should be noted that in this study, the "maintenance" period was only two weeks – but according to the authors, this can be sustained for an entire sporting season.

Results in Perspective

The results demonstrate that the detection power of the WADA test is poor and that agreement in analytical results from two WADA-accredited laboratories is very poor. Given these and other findings, the researchers conclude that improvements in the current rHuEpo test are necessary, or that alternative tests should be developed. This however, seems unlikely to occur before major events scheduled for 2008 like the Tour de France or the Olympic Games in Beijing.


Source: American Physiological Society

Explore further: Were clinical trial practices in East Germany questionable?

add to favorites email to friend print save as pdf

Related Stories

Roads negatively affect frogs and toads, study finds

Oct 17, 2014

The development of roads has a significant negative and pervasive effect on frog and toad populations, according to a new study conducted by a team of researchers that included undergraduate students and ...

Unstoppable magnetoresistance

Oct 09, 2014

Mazhar Ali, a fifth-year graduate student in the laboratory of Bob Cava, the Russell Wellman Moore Professor of Chemistry at Princeton University, has spent his academic career discovering new superconductors, ...

The case for a mission to Mars' moon Phobos

Oct 02, 2014

Ask any space enthusiast, and almost anyone will say humankind's ultimate destination is Mars. But NASA is currently gearing up to go to an asteroid. While the space agency says its Asteroid Initiative will ...

Scientific instruments of Rosetta's Philae lander

Sep 23, 2014

When traveling to far off lands, one packs carefully. What you carry must be comprehensive but not so much that it is a burden. And once you arrive, you must be prepared to do something extraordinary to make ...

Recommended for you

Were clinical trial practices in East Germany questionable?

Oct 23, 2014

Clinical trials carried out in the former East Germany in the second half of the 20th century were not always with the full knowledge or understanding of participants with some questionable practices taking place, according ...

Schumacher's doctor sees progress after injury

Oct 23, 2014

A French physician who treated Michael Schumacher for nearly six months after the Formula One champion struck his head in a ski accident says he is no longer in a coma and predicted a possible recovery within three years.

User comments : 0